Evidence map›Paper›PMID 39811215›Full record

ArticleCureus2024

Comparison of Different Machine Learning Models for Predicting Long-Term Overall Survival in Non-metastatic Colorectal Cancers.

Fahriye Tugba Kos, Songul Cecen Kaynak, Selin Aktürk Esen, Hilal Arslan, Dogan Uncu

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fahriye Tugba KosDepartment of Medical Oncology, Ankara Bilkent City Hospital, Ankara, TUR.
Songul Cecen KaynakDepartment of Software Engineering, Faculty of Engineering and Natural Sciences, Ankara Yıldırım Beyazıt University, Ankara, TUR.
Selin Aktürk EsenDepartment of Medical Oncology, Ankara Bilkent City Hospital, Ankara, TUR.
Hilal ArslanDepartment of Software Engineering, Faculty of Engineering and Natural Sciences, Ankara Yıldırım Beyazıt University, Ankara, TUR.
Dogan UncuDepartment of Medical Oncology, Ankara Bilkent City Hospital, Ankara, TUR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn recent years, machine learning (ML) methods have gained significant popularity among medical researchers interested in cancer. We aimed to test different (ML) models to predict both overall survival and survival at specific time points in patients with non-metastatic colorectal cancer (CRC).

methodsThe clinicopathological and treatment data of non-metastatic CRC patients with more than 10 years of follow-up at a single center were retrospectively reviewed. 1, 2, 3, 5, and 10-year survival rates for all patients and stages I-III were statistically calculated using the Kaplan-Meier method. Five distinct machine-learning algorithms were employed to develop predictive models for patient survival at five designated time points.

resultsA total of 498 patients were included in the study. The decision tree model had the highest area under the curve (AUC) for 1-year survival prediction (0.89). The ensemble model had the highest AUC for predicting 2-year, 3-year, and 5-year survival predictions (0.86, 0.92, and 0.89, respectively), while the support vector machine model had the highest AUC (0.84) for predicting 10-year survival. When considering the stages separately and assessing survival for the designated time intervals, the accuracy of all five models was found to be similar, ranging around 70% or higher.

conclusionML models can predict short- and long-term survival in patients with CRC, both for the overall patient population and when stratified by stage.

Indexed as

artificial intelligence (ai)(crc) colorectal carcinomamachine learning (ml)non-metastaticsurvival

Identifiers

PMID39811215
PMCPMC11730731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.